These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19936703)

  • 1. Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease.
    Nathanson D; Zethelius B; Berne C; Holst JJ; Sjöholm A; Nyström T
    Diabetologia; 2010 Feb; 53(2):277-80. PubMed ID: 19936703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
    Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
    Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
    Laakso M; Zilinskaite J; Hansen T; Boesgaard TW; Vänttinen M; Stancáková A; Jansson PA; Pellmé F; Holst JJ; Kuulasmaa T; Hribal ML; Sesti G; Stefan N; Fritsche A; Häring H; Pedersen O; Smith U;
    Diabetologia; 2008 Mar; 51(3):502-11. PubMed ID: 18080106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of incretin on early-phase insulin secretion and glucose excursion.
    Shen J; Chen Z; Chen C; Zhu X; Han Y
    Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Protein/Lipid Preload Attenuates Glucose-Induced Endothelial Dysfunction in Individuals with Abnormal Glucose Tolerance.
    Tricò D; Nesti L; Frascerra S; Baldi S; Mengozzi A; Natali A
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GLP-1 response to glucose does not mediate beta and alpha cell dysfunction in Hispanics with abnormal glucose metabolism.
    Adams E; Genter P; Keefe E; Sandow K; Gray V; Rotter JI; Chen YI; Ipp E
    Diabetes Res Clin Pract; 2018 Jan; 135():185-191. PubMed ID: 29155153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance.
    Marathe CS; Pham H; Marathe JA; Trahair LG; Huynh L; Wu T; Phillips LK; Rayner CK; Nauck MA; Horowitz M; Jones KL
    Acta Diabetol; 2020 May; 57(5):583-587. PubMed ID: 31848710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
    Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
    Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA
    Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
    Ahrén B; Larsson H
    Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.